Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 778

1.

Cost-effectiveness of systematic depression treatment for high utilizers of general medical care.

Simon GE, Manning WG, Katzelnick DJ, Pearson SD, Henk HJ, Helstad CS.

Arch Gen Psychiatry. 2001 Feb;58(2):181-7.

PMID:
11177120
2.

Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.

Simon GE, Katon WJ, Lin EH, Rutter C, Manning WG, Von Korff M, Ciechanowski P, Ludman EJ, Young BA.

Arch Gen Psychiatry. 2007 Jan;64(1):65-72.

PMID:
17199056
3.

Cost-effectiveness of a program to prevent depression relapse in primary care.

Simon GE, Von Korff M, Ludman EJ, Katon WJ, Rutter C, Unützer J, Lin EH, Bush T, Walker E.

Med Care. 2002 Oct;40(10):941-50.

PMID:
12395027
4.

Randomized trial of a depression management program in high utilizers of medical care.

Katzelnick DJ, Simon GE, Pearson SD, Manning WG, Helstad CP, Henk HJ, Cole SM, Lin EH, Taylor LH, Kobak KA.

Arch Fam Med. 2000 Apr;9(4):345-51.

PMID:
10776363
5.

Cost-effectiveness of improving primary care treatment of late-life depression.

Katon WJ, Schoenbaum M, Fan MY, Callahan CM, Williams J Jr, Hunkeler E, Harpole L, Zhou XH, Langston C, Unützer J.

Arch Gen Psychiatry. 2005 Dec;62(12):1313-20.

PMID:
16330719
6.

Cost-effectiveness of treatments for major depression in primary care practice.

Lave JR, Frank RG, Schulberg HC, Kamlet MS.

Arch Gen Psychiatry. 1998 Jul;55(7):645-51.

PMID:
9672056
7.

Cost-effectiveness of an intervention to prevent depression in at-risk teens.

Lynch FL, Hornbrook M, Clarke GN, Perrin N, Polen MR, O'Connor E, Dickerson J.

Arch Gen Psychiatry. 2005 Nov;62(11):1241-8.

PMID:
16275811
8.

Health care costs of primary care patients with recognized depression.

Simon GE, VonKorff M, Barlow W.

Arch Gen Psychiatry. 1995 Oct;52(10):850-6.

PMID:
7575105
9.

Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression.

Katon W, Unützer J, Fan MY, Williams JW Jr, Schoenbaum M, Lin EH, Hunkeler EM.

Diabetes Care. 2006 Feb;29(2):265-70.

PMID:
16443871
10.

Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder.

Katon WJ, Roy-Byrne P, Russo J, Cowley D.

Arch Gen Psychiatry. 2002 Dec;59(12):1098-104.

PMID:
12470125
11.

Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.

Revicki DA, Simon GE, Chan K, Katon W, Heiligenstein J.

J Fam Pract. 1998 Dec;47(6):446-52.

PMID:
9866670
12.

Cost-effectiveness of a collaborative care program for primary care patients with persistent depression.

Simon GE, Katon WJ, VonKorff M, Unützer J, Lin EH, Walker EA, Bush T, Rutter C, Ludman E.

Am J Psychiatry. 2001 Oct;158(10):1638-44.

PMID:
11578996
13.

Long-term effectiveness and cost of a systematic care program for bipolar disorder.

Simon GE, Ludman EJ, Bauer MS, Unützer J, Operskalski B.

Arch Gen Psychiatry. 2006 May;63(5):500-8.

PMID:
16651507
14.

Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization.

Henk HJ, Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW.

Arch Gen Psychiatry. 1996 Oct;53(10):899-904.

PMID:
8857866
15.

The costs and benefits of enhanced depression care to employers.

Wang PS, Patrick A, Avorn J, Azocar F, Ludman E, McCulloch J, Simon G, Kessler R.

Arch Gen Psychiatry. 2006 Dec;63(12):1345-53.

PMID:
17146009
16.

Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants.

Bosmans JE, Brook OH, van Hout HP, de Bruijne MC, Nieuwenhuyse H, Bouter LM, Stalman WA, van Tulder MW.

Pharmacoeconomics. 2007;25(1):25-37.

PMID:
17192116
17.

Modelling the cost effectiveness of antidepressant treatment in primary care.

Revicki DA, Brown RE, Palmer W, Bakish D, Rosser WW, Anton SF, Feeny D.

Pharmacoeconomics. 1995 Dec;8(6):524-40.

PMID:
10160081
18.

Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women.

Revicki DA, Siddique J, Frank L, Chung JY, Green BL, Krupnick J, Prasad M, Miranda J.

Arch Gen Psychiatry. 2005 Aug;62(8):868-75.

PMID:
16061764
19.

Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.

Pyne JM, Fortney JC, Tripathi SP, Maciejewski ML, Edlund MJ, Williams DK.

Arch Gen Psychiatry. 2010 Aug;67(8):812-21. doi: 10.1001/archgenpsychiatry.2010.82.

PMID:
20679589
20.

A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.

Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, Chatwin J, Goddard J, Thornett A, Smith H, Campbell M, Thompson C.

Health Technol Assess. 2005 May;9(16):1-134, iii.

Supplemental Content

Support Center